63 related articles for article (PubMed ID: 6484332)
21. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
[TBL] [Abstract][Full Text] [Related]
22. Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia.
Vakkilainen J; Pajukanta P; Cantor RM; Nuotio IO; Lahdenperä S; Ylitalo K; Pihlajamäki J; Kovanen PT; Laakso M; Viikari JS; Peltonen L; Taskinen MR
Eur J Hum Genet; 2002 Sep; 10(9):547-52. PubMed ID: 12173032
[TBL] [Abstract][Full Text] [Related]
23. Point mutations in lipoprotein lipase (LPL) gene: prevalence in normal and combined hyperlipidemic subjects.
Gehrisch S; Steinke M; Kostka H; Hoche I; Julius U; Jaross W
Z Gastroenterol; 1996 Jun; 34 Suppl 3():64-5. PubMed ID: 8767466
[No Abstract] [Full Text] [Related]
24. Complex segregation analysis of hyperlipidemia in a Seattle sample.
Williams WR; Lalouel JM
Hum Hered; 1982; 32(1):24-36. PubMed ID: 7068156
[No Abstract] [Full Text] [Related]
25. Role of insulin resistance in familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
[TBL] [Abstract][Full Text] [Related]
26. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
[TBL] [Abstract][Full Text] [Related]
27. Study of genetic variants of familial hyperlipidaemia in some xanthoma patients.
Gajra B; Talukder G; Panja SK
Indian J Dermatol; 1981 Jul; 26(3):1-3. PubMed ID: 7348242
[No Abstract] [Full Text] [Related]
28. Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia.
Avisar I; Brook JG; Wolfovitz E
Eur J Intern Med; 2008 May; 19(3):203-8. PubMed ID: 18395165
[TBL] [Abstract][Full Text] [Related]
29. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
Ribalta J; La Ville AE; Heras M; Plana N; Masana L
Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
[TBL] [Abstract][Full Text] [Related]
30. Familial combined hyperlipidemia in a North Indian kindred.
Sriram CS; Gulati S; Chopra V; Vashist S; Menon PS
Indian J Pediatr; 2005 Nov; 72(11):987-9. PubMed ID: 16391457
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein A-II: active or passive role in familial combined hyperlipidemia.
Aouizerat BE; Kane JP
Circ Res; 2003 Jun; 92(11):1179-81. PubMed ID: 12805235
[No Abstract] [Full Text] [Related]
32. Low-density lipoprotein subclass phenotypes and familial combined hyperlipidemia.
Austin MA
Diabetes Metab Rev; 1991 Sep; 7(3):173-7. PubMed ID: 1817002
[No Abstract] [Full Text] [Related]
33. Combined familial hyperlipidaemia in association with apolipoprotein E3 phenotype.
Kelly JA; Robinson K; Tighe OP; Dickson B; Tomkin GH; Collins PB; Johnson AH
Biochem Soc Trans; 1990 Aug; 18(4):631. PubMed ID: 2276482
[No Abstract] [Full Text] [Related]
34. Familial combined hyperlipidemia and otosclerosis--the occurrence in a large kindred.
Levy Y; da Silva M; Eliachar I; Glick-Avraham Z; Viskoper RJ; Brook JG
Am J Med Sci; 1985 Mar; 289(3):107-9. PubMed ID: 3976713
[TBL] [Abstract][Full Text] [Related]
35. [Multiple bone necroses and familial type I hyperlipemia. Apropos of a case report].
Arlet J; Franck JL; Nghiem L; Solera ML; de Graeve J
Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):149-53. PubMed ID: 6857128
[No Abstract] [Full Text] [Related]
36. [Familial combined hyperlipidemia].
Mabuchi H; Nohara A; Nozue T; Koizumi J; Uno Y
Nihon Naika Gakkai Zasshi; 2001 Aug; 90(8):1538-43. PubMed ID: 11573278
[No Abstract] [Full Text] [Related]
37. New technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia.
Horswell SD; Ringham HE; Shoulders CC
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S370-5. PubMed ID: 19023136
[TBL] [Abstract][Full Text] [Related]
38. [Familial combined hyperlipidemia].
Inoue I
Nihon Rinsho; 2007 Jul; 65 Suppl 7():309-20. PubMed ID: 17824049
[No Abstract] [Full Text] [Related]
39. [Dyslipidemic hypertension].
Cambien F
Rev Prat; 1988 Oct; 38(22):1558-9. PubMed ID: 3206140
[No Abstract] [Full Text] [Related]
40. [Combined familial hyperlipidemia. Study of a family].
Ahumada-Ayala M; Lozano-Castañeda O; Rull JA; Valles VE; Wong B
Rev Invest Clin; 1984; 36(2):141-5. PubMed ID: 6484332
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
